miRNAs as important drivers of glioblastomas: a no-brainer?

Area of Science:

• Molecular Oncology
• Biomarker Discovery
• Cancer Therapeutics

Background:

• MicroRNAs (miRNAs) are critical in cancer pathogenesis, with both oncogenic and tumor-suppressive roles identified in glioblastoma multiforme (GBM).
• GBM is an aggressive brain tumor with a poor prognosis, necessitating novel diagnostic and therapeutic approaches.
• Differential expression of miRNAs in cancer models highlights their potential as therapeutic targets and diagnostic/prognostic biomarkers.

Purpose of the Study:

• To review differentially expressed miRNAs in glioblastoma multiforme.
• To explore the utility of circulating miRNAs for non-invasive cancer diagnosis and monitoring treatment response.
• To discuss current strategies for developing miRNA-based therapeutics and summarize preclinical findings in GBM.

Main Methods:

• Literature review of studies on miRNA expression in glioblastoma.
• Analysis of research on circulating miRNAs for cancer diagnostics and prognostics.
• Examination of preclinical data for miRNA-targeted therapies in GBM.

Main Results:

• Numerous miRNAs exhibit differential expression in GBM, indicating their involvement in tumorigenesis.
• Circulating miRNAs show promise as non-invasive biomarkers for GBM diagnosis and predicting response to chemotherapy.
• Preclinical studies demonstrate the potential of miRNA-based therapeutics for GBM treatment.

Conclusions:

• miRNAs are significant players in GBM pathogenesis and hold potential as biomarkers.
• Circulating miRNAs offer a promising avenue for non-invasive diagnostics and treatment monitoring in GBM.
• Targeting miRNAs represents a viable therapeutic strategy for GBM, with ongoing preclinical development.